The New England journal of medicine, 2024-05, Vol.390 (19), p.1745-1755
- Connolly, Stuart J.
- Sharma, Mukul
- Cohen, Alexander T.
- Demchuk, Andrew M.
- Członkowska, Anna
- Lindgren, Arne G.
- Molina, Carlos A.
- Bereczki, Daniel
- Toni, Danilo
- Seiffge, David J.
- Tanne, David
- Sandset, Else Charlotte
- Tsivgoulis, Georgios
- Christensen, Hanne
- Beyer-Westendorf, Jan
- Coutinho, Jonathan M.
- Crowther, Mark
- Verhamme, Peter
- Amarenco, Pierre
- Roine, Risto O.
- Mikulik, Robert
- Lemmens, Robin
- Veltkamp, Roland
- Middeldorp, Saskia
- Robinson, Thompson G.
- Milling, Truman John
- Tedim-Cruz, Vitor
- Lang, Wilfried
- Himmelmann, Anders
- Ladenvall, Per
- Knutsson, Mikael
- Ekholm, Ella
- Law, Andrew
- Taylor, Amanda
- Karyakina, Tetyana
- Xu, Lizhen
- Tsiplova, Kate
- Poli, Sven
- Kallmünzer, Bernd
- Gumbinger, Christoph
- Shoamanesh, Ashkan
2024
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Connolly, Stuart J.
- Sharma, Mukul
- Cohen, Alexander T.
- Demchuk, Andrew M.
- Członkowska, Anna
- Lindgren, Arne G.
- Molina, Carlos A.
- Bereczki, Daniel
- Toni, Danilo
- Seiffge, David J.
- Tanne, David
- Sandset, Else Charlotte
- Tsivgoulis, Georgios
- Christensen, Hanne
- Beyer-Westendorf, Jan
- Coutinho, Jonathan M.
- Crowther, Mark
- Verhamme, Peter
- Amarenco, Pierre
- Roine, Risto O.
- Mikulik, Robert
- Lemmens, Robin
- Veltkamp, Roland
- Middeldorp, Saskia
- Robinson, Thompson G.
- Milling, Truman John
- Tedim-Cruz, Vitor
- Lang, Wilfried
- Himmelmann, Anders
- Ladenvall, Per
- Knutsson, Mikael
- Ekholm, Ella
- Law, Andrew
- Taylor, Amanda
- Karyakina, Tetyana
- Xu, Lizhen
- Tsiplova, Kate
- Poli, Sven
- Kallmünzer, Bernd
- Gumbinger, Christoph
- Shoamanesh, Ashkan
- Titel
- Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage
- Ist Teil von
- The New England journal of medicine, 2024-05, Vol.390 (19), p.1745-1755
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2024
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- The factor Xa inhibitor reversal agent andexanet reduced expansion of intracerebral hemorrhages caused by factor Xa inhibitors but resulted in more thrombotic events than usual care.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2313040Titel-ID: cdi_pubmed_primary_38749032
- Format
- –
- Schlagworte
- Acute Disease, Aged, Aged, 80 and over, Atrial Fibrillation - complications, Atrial Fibrillation - drug therapy, Cerebral Hemorrhage - chemically induced, Cerebral Hemorrhage - drug therapy, Clinical Medicine, Coagulation, Committees, Drug dosages, Emergency Medicine, Emergency Medicine General, Factor Xa - adverse effects, Factor Xa - therapeutic use, Factor Xa Inhibitors - adverse effects, Factor Xa Inhibitors - therapeutic use, FDA approval, Female, Hematology, Hematology/Oncology, Hematoma, Hematoma - chemically induced, Hematoma - drug therapy, Hemorrhage, Humans, International organizations, Ischemia, Klinisk medicin, Magnetic resonance imaging, Male, Medical and Health Sciences, Medical research, Medicin och hälsovetenskap, Middle Aged, Neurologi, Neurology, Neurology/Neurosurgery, Neurosurgery, Oncology, Prothrombin, Recombinant Proteins - adverse effects, Recombinant Proteins - therapeutic use, Research centers, Statistical analysis, Stroke